SEARCH

SEARCH BY CITATION

References

  • 1
    Christakos, S. & H.F. DeLuca. 2011. Minireview: Vitamin D: is there a role in extraskeletal health? Endocrinology 152: 29302936.
  • 2
    Dhawan, P., R. Wieder & S. Christakos. 2009. CCATT enhancer binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J. Biol. Chem. 284: 30863095.
  • 3
    Joshi, S., L.-C. Pantalena, X. K. Liu, et al. 2011. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31: 36533669.
  • 4
    Liu, P.T. et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 17701773.
  • 5
    Hewison, M. 2011. Antibacterial effects of vitamin D. Nat. Rev. Endocrinol. 7: 337345.
  • 6
    Hewison, M. et al. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170: 53825390.
  • 7
    Jeffery, L.E. et al. 2012. Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses. J. Immunol. 189: 51555164.
  • 8
    Gardner, D.G., S. Chen, D.J. Glenn & W. Ni. 2011. Vitamin D and the Cardiovascular System. In: Vitamin D, 3rd Edition. D.J.W. Feldman, Pike and J.S. Adams, eds: 541563. Elsevier: New York.
  • 9
    Li, Y.C., J. Kong, M. Wei, et al. 2002. 1,25-dihydroxyvitamin D(3) is a Negative Endocrine Regulator of the Renin-Angiotensin System. J. Clin. Invest. 110: 229238.
  • 10
    Chen, S. & D.G. Gardner. Liganded Vitamin D Receptor Displays Anti-Hypertrophic Activity in the Murine Heart. J. Steroid. Biochem. Mol. Biol., in press.
  • 11
    Chen, S., C.S. Law, C.L. Grigsby, et al. 2011. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124: 18381847.
  • 12
    Hollis, B.W., D. Johnson, T.C. Hulsey, et al. 2011. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone. Miner. 26(10): 23412357. PMCID: 3183324.
  • 13
    Mahomed, K. & A.M. Gulmezoglu. 1999. Vitamin D supplementation in pregnancy (Cochrane Review). Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. Chicester, UK.
  • 14
    De-Regil, L.M., C. Palacios, A. Ansary, et al. 2012. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2: CD008873.
  • 15
    Hollis, B.W. & C.L. Wagner. 2012. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue. Int.
  • 16
    Wagner, C.L., R. McNeil, S.A. Hamilton, et al. 2012. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol.
  • 17
    Wagner, C.L., T.C. Hulsey, D. Fanning, et al. 2006. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 1: 5970.
  • 18
    Wagner, C.L., C. Howard, T.C. Hulsey, et al. 2012. Preliminary Results of a Randomized Controlled Trial of Maternal Supplementation with 6400 IU Vitamin D/day Compared with Maternal & Infant Supplementation of 400 IU/day in Achieving Sufficiency in the Breastfeeding Mother-Infant Dyad. Intl. Society Res. Human Milk Lactation. in press (abstract).
  • 19
    Sergeev, I.N. 2009. Novel mediators of vitamin D signaling in cancer and obesity. Immun. Endoc. Metab. Agents Med. Chem. 9: 153158.
  • 20
    Song, Q. & I.N. Sergeev. 2012. Calcium and vitamin D in obesity. Nutr. Res. Rev. 25: 130141.
  • 21
    Sergeev, I.N. 2012. Vitamin D and cellular Ca2+ signaling in breast cancer. Anticancer Res. 32: 299302.
  • 22
    Sergeev, I.N. 2005. Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol. 97: 145151.
  • 23
    Sergeev, I.N. 2009. 1,25-Dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Commun. 384: 1824.
  • 24
    Janssens, W. et al. 2009. Vitamin D Beyond Bones in COPD: Time to Act. Am. J. Respir Crit. Care Med.
  • 25
    Janssens, W. et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 65(3): 215220.
  • 26
    Romme, E.A. et al. 2012. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann. Med.
  • 27
    Persson, L.J. et al. 2012. Chronic obstructive pulmonary disease is associated with low levels of vitamin d. PLoS One 7(6): e38934.
  • 28
    Forli, L. et al. 2004. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J. Intern. Med. 256(1): 5662.
  • 29
    Hopkinson, N.S. et al. 2008. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 87(2): 385390.
  • 30
    Lehouck, A. et al. 2012. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 156(2): 105114.
  • 31
    Black, P.N. & R. Scragg. 2005. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128(6): 37923798.
  • 32
    Kumar, V.A., D.A. Kujubu, J.J. Sim, et al. 2011. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J. Nephrol. 24(1): 98105.
  • 33
    Andrews, N.C. 2004. Anemia of inflammation:the cytokine-hepcidin link. J. Clin. Invest. 113(9): 12511253.
  • 34
    Howick, J., P. Glasziou & J.K. Aronson. 2009. The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute? J. Royal Soc. Med. 102: 186194.
  • 35
    Mitri, J., M.D. Muraru & A.G. Pittas. 2011. Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 65: 10051015.
  • 36
    Song, Y., L. Wang, A.G. Pittas, et al. Blood 25-hydroxyvitamin D concentration and incident Type 2 Diabetes: A meta-analysis of prospective studies diabetes care (in press).
  • 37
    Pittas, A.G. et al. 2007. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30: 980986.
  • 38
    von Hurst, P.R. et al. 2008. Study protocol–metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. BMC Public Health 8: 267.
  • 39
    Mitri, J. et al. 2011. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94: 486494.
  • 40
    Boland, R. 1986. Role of vitamin D in skeletal muscle function. Endocr. Rev. 7: 434448.
  • 41
    Gallagher, J.C. 2004. The effects of calcitriol on falls and fractures and physical performance tests. J. Steroid Biochem. Mol. Biol. 89–90: 497501.
  • 42
    Bischoff, H.A., M. Borchers, F. Gudat, et al. 2001. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33: 1924.
  • 43
    Boland, R. 2005. Vitamin D and Muscle. In: Vitamin D. 2nd. Edition; D. Feldman, G. Glorieux & W. Pike, eds: 885898. Academic Press. CA, USA. Chapter 55.
  • 44
    Boland, R. 2011. VDR activation of intracellular signaling pathways in skeletal muscle. Mol. Cell. Endocrinol. 34: 1116.
  • 45
    Boland, R., A.R. de Boland, C. Buitrago, et al. 2002. Non-genomic stimulation of tyrosine phosphorylation cascades by 1,25(OH)2D3 by VDR-dependent and -independent mechanisms in muscle cells. Steroids 67: 477482.
  • 46
    Capiati, D., S. Benassati & R. Boland. 2002. 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J. Cell. Biochem. 86: 128135.
  • 47
    Houston, D.K., R.H. Neiberg, J.A. Tooze, et al. 2013. Low 25-hydroxyvitamin D predicts the onset of mobility limitation and disability in community-dwelling older adults: The health ABC study. J. Gerontol. A Biol. Sci. Med. Sci. 68(2): 181187.
  • 48
    Rock, C.L., J.A. Emond, S.W. Flatt, et al. 2012. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity. 20(11): 22962301.
  • 49
    Visser, M., D.J. Deeg, P. Lips, Longitudinal Aging Study Amsterdam. 2003. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study amsterdam. J. Clin. Endocrinol. Metab. 88(12): 57665772.
  • 50
    Giallauria, F., Y. Milaneschi, T. Tanaka, et al. 2012. Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J. Clin. Endocrinol. Metab. 97(10): 37173723.
  • 51
    Silvagno, F., E. De Vivo, A. Attanasio, et al. 2010. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One. 5(1): e8670.
  • 52
    Krishnan, A.V. & D. Feldman. 2011. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu. Rev. Pharmacol. Toxicol. 51: 311336.
  • 53
    Llewellyn, D.J., I.A. Lang, K.M. Langa, et al. 2010. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 170(13): 11351141.
  • 54
    Milaneschi, Y., M. Shardell, A.M. Corsi, et al. 2010. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J. Clin. Endocrinol. Metab. 95(7): 32253233.
  • 55
    Institute of Medicine. 2011. Dietary reference intakes for calcim and vitamin D. Washington DC: The National Academies Press.
  • 56
    Holick, M.F., N.C. Binkley, H.A. Bischoff-Ferrari, et al. 2011. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96: 19111930
  • 57
    Looker, A.C., C.L. Johnson, D.A. Lacher, et al. 2011. Vitamin D status: United States, 2001–2006. National Center for Health Statistics Data Brief no 59.
  • 58
    Kuchuk, N.O., N.M. van Schoor, S.M. Pluijm, et al. 2009. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J. Bone. Min. Res. 24: 693701.
  • 59
    Binkley, N., D.C. Krueger, S. Morgan & D. Wiebe. 2010. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin. Chim. Acta. 411: 19761982
  • 60
    Christakos, S., P. Dhawan, Y. Liu, et al. 2003. New Insights into the mechanisms of vitamin D action. J. Cell. Biochem. 88: 695705.